Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-10-16 Sale | 2019-10-18 5:13 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 133,484 | $6.3749 | $850,947 | 91,266 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-10 Option Award | 2022-05-12 8:28 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-20 08:48 am | N/A 2031-05-12 | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 8,300 | $0 | 8,300 (Direct) | View |
| 2020-12-02 Disposition | 2020-12-02 09:45 am | N/A 2030-05-28 | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Truitt Joseph CEO | 100,000 | $24.78 | 0 (Direct) | View |
| 2020-05-28(A) Option Award | 2020-10-19 4:15 pm | N/A 2030-05-28 | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Truitt Joseph CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-09-29 Option Award | 2020-09-30 2:00 pm | N/A 2030-07-16 | Larimar Therapeutics Inc. | LRMR | Truitt Joseph Director | 16,600 | $0 | 16,600 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 2:32 pm | N/A 2030-05-28 | BIOSPECIFICS TECHNOLOGIES CORP | BSTC | Truitt Joseph CEO | 130,000 | $0 | 130,000 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 3,500 | $6.3 | 0 (Direct) | View |
| 2020-01-28 Disposition | 2020-01-29 4:15 pm | N/A 2026-01-20 | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 2,892,766 | $0 | 0 (Direct) | View |
| 2019-10-16 Exercise | 2019-10-18 5:13 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 33,250 | $3.28 | 91,266 (Direct) | View |
| 2019-10-16 Exercise | 2019-10-18 5:13 pm | N/A N/A | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 100,234 | $3.1 | 91,266 (Direct) | View |
| 2019-10-16 Exercise | 2019-10-18 5:13 pm | N/A 2019-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 133,484 | $0 | 91,266 (Direct) | View |
| 2019-01-23 Option Award | 2019-01-25 4:50 pm | N/A 2029-01-23 | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 1,097,000 | $0 | 1,097,000 (Direct) | View |
| 2018-05-01 Option Award | 2018-05-03 4:59 pm | N/A 2028-05-01 | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph CEO | 632,000 | $0 | 632,000 (Direct) | View |
| 2018-02-09 Option Award | 2018-02-13 5:21 pm | N/A 2028-02-09 | ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph Chief Commercial Officer | 419,000 | $0 | 419,000 (Direct) | View |